Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a novel 2-oxindole fluorinated derivative as in vivo antitumor agent for prostate cancer acting via AMPK activation
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-03-06
DOI
10.1038/s41598-018-22690-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metformin Has a Positive Therapeutic Effect on Prostate Cancer in Patients With Type 2 Diabetes Mellitus
- (2016) R. William Chong et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Compound C inhibits macrophage chemotaxis through an AMPK-independent mechanism
- (2016) Youngyi Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators
- (2016) Kimberly O. Cameron et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Combinational strategies of metformin and chemotherapy in cancers
- (2016) Hui-Hui Zhang et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Combining p53 stabilizers with metformin induces synergistic apoptosis through regulation of energy metabolism in castration-resistant prostate cancer
- (2016) Long Chen et al. CELL CYCLE
- Does Metformin Reduce Cancer Risks? Methodologic Considerations
- (2016) Asieh Golozar et al. Current Diabetes Reports
- Androgen control of lipid metabolism in prostate cancer: novel insights and future applications
- (2016) Lisa M Butler et al. ENDOCRINE-RELATED CANCER
- AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours
- (2016) Fiona A. Ross et al. FEBS Journal
- Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer
- (2016) Christel Häggström et al. INTERNATIONAL JOURNAL OF CANCER
- Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy
- (2016) Kimberly O. Cameron et al. JOURNAL OF MEDICINAL CHEMISTRY
- AMPK Causes Cell Cycle Arrest in LKB1-Deficient Cells via Activation of CAMKK2
- (2016) S. Fogarty et al. MOLECULAR CANCER RESEARCH
- Metformin induces degradation of cyclin D1 via AMPK/GSK3β axis in ovarian cancer
- (2016) HyeRan Gwak et al. MOLECULAR CARCINOGENESIS
- Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells
- (2016) Simeng Wen et al. MOLECULAR CARCINOGENESIS
- Cancer metabolism: a therapeutic perspective
- (2016) Ubaldo E. Martinez-Outschoorn et al. Nature Reviews Clinical Oncology
- Glucose Alters Per2 Rhythmicity Independent of AMPK, Whereas AMPK Inhibitor Compound C Causes Profound Repression of Clock Genes and AgRP in mHypoE-37 Hypothalamic Neurons
- (2016) Johanneke E. Oosterman et al. PLoS One
- Loss of STK11 expression is an early event in prostate carcinogenesis and predicts therapeutic response to targeted therapy against MAPK/p38
- (2015) Valentina Grossi et al. Autophagy
- Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
- (2015) R.Brooks Robey et al. CARCINOGENESIS
- Targeting the 5′-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancer
- (2015) Petra Popovics et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Pharmacological Targeting of AMP-Activated Protein Kinase and Opportunities for Computer-Aided Drug Design
- (2015) Marie Miglianico et al. JOURNAL OF MEDICINAL CHEMISTRY
- Metformin effects on biochemical recurrence and metabolic signaling in the prostate
- (2015) Brian Winters et al. PROSTATE
- Low LKB1 Expression Results in Unfavorable Prognosis in Prostate Cancer Patients
- (2015) Jianlei Lu et al. MEDICAL SCIENCE MONITOR
- Transcriptomic analysis reveals inhibition of androgen receptor activity by AMPK in prostate cancer cells
- (2015) Sarah Jurmeister et al. Oncotarget
- A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis
- (2014) G. Zadra et al. EMBO Molecular Medicine
- Small Molecule Adenosine 5′-Monophosphate Activated Protein Kinase (AMPK) Modulators and Human Diseases
- (2014) Sandeep Rana et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synergistic Simvastatin and Metformin Combination Chemotherapy for Osseous Metastatic Castration-Resistant Prostate Cancer
- (2014) M. A. Babcook et al. MOLECULAR CANCER THERAPEUTICS
- The AMPK Inhibitor Compound C Is a Potent AMPK-Independent Antiglioma Agent
- (2014) X. Liu et al. MOLECULAR CANCER THERAPEUTICS
- Structural Basis for AMPK Activation: Natural and Synthetic Ligands Regulate Kinase Activity from Opposite Poles by Different Molecular Mechanisms
- (2014) Matthew F. Calabrese et al. STRUCTURE
- AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
- (2013) Madhumita Dandapani et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The fat side of prostate cancer
- (2013) Giorgia Zadra et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle
- (2013) S. M. Hadad et al. Clinical & Translational Oncology
- Estimation of rat mammary tumor volume using caliper and ultrasonography measurements
- (2013) Ana Faustino-Rocha et al. LAB ANIMAL
- Development of Novel Alkene Oxindole Derivatives As Orally Efficacious AMP-Activated Protein Kinase Activators
- (2013) Li-Fang Yu et al. ACS Medicinal Chemistry Letters
- Structural basis of AMPK regulation by small molecule activators
- (2013) Bing Xiao et al. Nature Communications
- Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation
- (2012) Ian P Salt et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan
- (2011) Antero Salminen et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- SU11248 (sunitinib) directly inhibits the activity of mammalian 5'-AMP-activated protein kinase (AMPK)
- (2010) Keith Laderoute et al. CANCER BIOLOGY & THERAPY
- Targeting Cancer Cell Metabolism: The Combination of Metformin and 2-Deoxyglucose Induces p53-Dependent Apoptosis in Prostate Cancer Cells
- (2010) I. Ben Sahra et al. CANCER RESEARCH
- Highly Enantioselective and Organocatalytic α-Amination of 2-Oxindoles
- (2009) Liang Cheng et al. ORGANIC LETTERS
- The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
- (2008) I Ben Sahra et al. ONCOGENE
- Tumor volume in subcutaneous mouse xenografts measured by microCT is more accurate and reproducible than determined by 18F-FDG-microPET or external caliper
- (2008) Mette Munk Jensen et al. BMC MEDICAL IMAGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started